The company is currently conducting a Phase II trial in prostate cancer.Ĭlick Here to get the full Stock Report for Tyme Technologies Inc stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
#TYME STOCK PRICE TODAY FREE#
SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. A high-level overview of Tyme Technologies, Inc. Research TYME stock prices, stock quotes, stock trends and. stock index futures jumped on Wednesday following two days of turbulent trading, helped by stellar results from Microsoft, while. Get todays stock prices, news and investor discussion about Tyme Technologies Inc. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. Markets JinkoSolar, Tyme Technologies, Texas Instruments. When is Tyme Technologies's earnings date Tyme Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates. Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. To see InvestorsObserver's Sentiment Score for Tyme Technologies Inc click here. So far 1,030,764 shares have traded compared to average volume of 2,066,627 shares. The stock has traded between $0.32 and $0.35 so far today. stealing as an ill action, disagreeing with the rule of right. Tyme Technologies Inc (TYME) stock is trading at $0.33 as of 12:02 PM on Thursday, Aug 4, a rise of $0.03, or 9.67% from the previous closing price of $0.30. Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology.
0 kommentar(er)
